Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 136 citing Keech: Secondary prevention of cardiovascular events with long-term pravastatin in patients.... (0.11 sec) 

Insulin resistance and the endothelium


WA Hsueh, CJ Lyon, MJ Quiñones - The American journal of medicine, 2004 - Elsevier
There is increasing evidence of a parallel progression between insulin resistance and endothelial
dysfunction, suggesting a close association between insulin action and the endothelium. Numerous
studies have demonstrated that ...
Cited by 151 - Related articles - All 9 versions

Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta …

- nih.gov
J Costa, M Borges, C David, AV Carneiro - British Medical Journal, 2006 - bmj.com
The prevalence of diabetes mellitus is increasing. Up to 218 mil- lion people are likely to have the
disease by 2010.1 The current understanding is that type 2 diabetes mellitus is a metabolic dis-
order, defined by hyperglycaemia, ...
Cited by 146 - Related articles - BL Direct - All 9 versions

Effect of lowering LDL cholesterol substantially below currently recommended …

- diabetesjournals.org
J Shepherd, P Barter, R Carmena, P Deedwania, … - Diabetes Care, 2006 - Am Diabetes Assoc
RESULTS—End-of-treatment mean LDL cholesterol levels were 98.6 mg/dl with atorvastatin 10 mg and
77.0 mg/dl with atorvastatin 80 mg. A primary event occurred in 135 patients (17.9%) receiving
atorvastatin 10 mg, compared with ...
Cited by 135 - Related articles - BL Direct - All 6 versions

A systematic review of drug therapy to delay or prevent type 2 diabetes

- diabetesjournals.org
R Padwal, SR Majumdar, JA Johnson, J Varney, FA … - Diabetes Care, 2005 - Am Diabetes Assoc
RESULTS—Ten studies of oral hypoglycemic agents and 15 studies of nonoral hypoglycemic agents were
found. Oral hypoglycemic agents and orlistat are the only drugs that have been studied in randomized
controlled trials with diabetes ...
Cited by 116 - Related articles - BL Direct - All 12 versions

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in …

- Free from Publisher
RH Knopp - Diabetes Care, 2006 - Am Diabetes Assoc
We mention in our article the high rates of treatment “drop in” and “drop out” and the
potential impact on the primary end point (mostly due to changing guidelines and study design
changes). While Gazi and ...
Cited by 101 - Related articles - BL Direct - All 8 versions

Insulin resistance and atherosclerosis

- nih.gov
CF Semenkovich - Journal of Clinical Investigation, 2006 - Am Soc Clin Investig
Considerable evidence supports the association between insulin resistance and vascular disease, and
this has led to wide acceptance of the clustering of hyperlipidemia, glucose intolerance,
hypertension, and obesity as a ...
Cited by 99 - Related articles - BL Direct - All 15 versions

Are statins created equal? Evidence from randomized trials of pravastatin, …


Z Zhou, E Rahme, L Pilote - American Heart Journal, 2006 - Elsevier
Using adjusted indirect comparison, we compared 3 statins (pravastatin, simvastatin, and
atorvastatin) based on published randomized placebo-controlled trials for long-term cardiovascular
prevention. A systematic literature ...
Cited by 50 - Related articles - All 21 versions

Stroke in patients with diabetes mellitus


BN Mankovsky, D Ziegler - Diabetes/Metabolism Reviews - interscience.wiley.com
The article's objective is to review the key advances in the scientific literature related to the
association of stroke with diabetes mellitus and to summarize the current approaches to stroke
prevention in diabetic patients. ...
Cited by 50 - Related articles - BL Direct - All 3 versions

Effect of pravastatin in people with diabetes and chronic kidney disease

- asnjournals.org
M Tonelli, A Keech, J Shepherd, F Sacks, A … - Journal of the American …, 2005 - Am Soc Nephrol
Although diabetes is a major cause of chronic kidney disease (CKD), limited data describe the
cardiovascular benefit of hydroxymethyl glutaryl CoA reductase inhibitors (statins) in people with
both of these conditions. This ...
Cited by 50 - Related articles - BL Direct - All 7 versions

Risk constellations in patients with the metabolic syndrome: epidemiology, …


SM Haffner - The American journal of medicine, 2006 - Elsevier
The prevalence of diabetes mellitus is increasing worldwide. Among other complications, diabetes is
associated with the risk of coronary heart disease (CHD) that is thought to be equal to the risk of
CHD in subjects without diabetes ...
Cited by 45 - Related articles - All 10 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google